Interferon Regulatory Factor (IRF)-1 has been characterized as an important growth regulatory and immunomodulatory transcription factor. To further characterize the potential targets of IRF-1 antiproliferative activity, IRF-1 was expressed under the control of the tetracycline-inducible system in murine NIH3T3 cells. Due to their ability to mimic IRF-1 transactivator function, the regulatory potential of IRF-1/RelA and IRF-2/RelA fusion proteins consisting of the DNA binding domains of IRF-1 or IRF-2 fused to the transactivation domain of NF-kB RelA(p65) was also examined. Cells inducibly expressing IRF-1 or IRF/RelA in response to doxycycline treatment displayed signi®-cantly reduced growth rates compared to control cells, and inhibition of cell growth correlated directly with the level of transgene expression. Interestingly, IRF-1 and IRF/RelA expression also induced a low level of apoptosis, as detected by microscopic analyses. Furthermore, expression of the interferon inducible, double stranded RNA dependent kinase PKR was increased following IRF-1 or IRF/RelA induction. Most strikingly, induction of IRF-1 and IRF/RelA expression resulted in a signi®cant increase in STAT1 (p91) protein and increased ISGF3 DNA binding activity, suggesting that IRF-1 tumor suppressor activity may involve a novel mechanism which activates the JAK-STAT pathway through STAT1. WAF1 levels were also constitutively elevated in IRF-1 and IRF-1/RelA cells. These studies demonstrate that inducible expression of the transactiva
Introduction
The Interferon Regulatory Factors-1 and -2 (IRF-1 and IRF-2) are transcription factors that play a role in the regulation of the IFN-b gene as well as other immunoregulatory genes (Thanos and Maniatis, 1995a,b; Xanthoudakis et al., 1989; Hiscott et al., 1989) . The availability of these factors is in¯uenced by the presence of various external stimuli, such as viruses and IFN treatment (Maniatis et al., 1992; Hiscott et al., 1995; Garoufalis et al., 1994) . Structurally, the two proteins are similar, sharing 62% homology in the ®rst 154 N-terminal amino acids and 25% homology at their C-terminal end (Harada et al., 1989) . Both proteins recognize the same DNA binding recognition site, 5'-G(A)AAAG/CT/CGAAAG/CT/C-3', but possess very dierent activities Miyamoto et al., 1988; Harada et al., 1989; Reis et al., 1992) . IRF-1 serves as a transcriptional activator of IFN-b and other genes, whereas IRF-2 acts as an antagonistic transcriptional repressor. The N-terminus of both proteins contains the DNA binding domain; in IRF-2, this region also represents the transcriptional repression domain. IRF-1 transactivation is contained within the C-terminal end (Uegaki et al., 1993; Yamamoto et al., 1994) .
The functional dierences between IRF-1 and IRF-2 extend further to include an important role in cellular growth regulation. IRF-1 and IRF-2 tumor suppressor and oncogenic activity was initially revealed by the hallmark experiment demonstrating IRF-2 induction of cellular transformation in NIH3T3 cells and tumor formation in nude mice, and reversal of the IRF-2-mediated tumorigenicity by IRF-1 . The transformation domain of IRF-2 has been mapped to the N-terminal 160 amino acids and correlates directly with DNA binding and transcriptional repression (Nguyen et al., 1995) .
Recent studies have further established the role of IRF-1 as a tumor suppressor. The IRF-1 gene maps to chromosome 5q31.1, a region which was consistently deleted at one or both alleles in each of 13 cases of leukemia and preleukemic myelodysplasia (Willman et al., 1993) . Furthermore, bone marrow and peripheral mononuclear cells from patients with myelodysplastic syndrome (MDS) or leukemia secondary to MDS preferentially express an`exon-skipped' IRF-1 mRNA which lacks exons 2 and 3; the protein product displayed neither DNA binding nor tumor suppressive activities, suggesting a mechanism for inactivation of IRF-1 and subsequent development of human hematopoietic malignancies . The tumor suppressor function of IRF-1 was further assessed in knockout mice de®cient in IRF-1, IRF-2 or both IRF proteins. Cells from mice de®cient in IRF-1 alone or both IRF-1 and IRF-2 were susceptible to transformation by the ras oncogene, whereas normal cells or cells from mice de®cient in IRF-2 were not transformed by ras. Interestingly, these non-transformed ras-expressing normal and IRF-2 de®cient cells, unlike the rastransformed IRF-1 de®cient and IRF double knockout cells, died by apoptosis under conditions of low serum, high density or exposure to anticancer drugs or ionizing radiation. These studies thus implicate IRF-1 as a critical tumor suppressor, regulating oncogeneinduced cell transformation or apoptosis .
Despite compelling evidence establishing the role of IRF-1 as an antioncogene, the mechanisms by which IRF-1 exerts its growth regulatory activities are not well elucidated. Expression of the double stranded RNA dependent protein kinase PKR, which like IRF-1 is an IFN-inducible gene with growth suppressive activity, correlates with IRF-1-mediated cell growth inhibition, suggesting that IRF-1 tumor suppressor activity may be mediated through PKR (Kircho et al., 1995) . Splenocytes from IRF-1 knockout mice are also de®cient in the interleukin-1b converting enzyme (ICE), a mammalian homologue of the Caenorhabditis elegans cell death gene ced-3; furthermore, ectopic overexpression of IRF-1 resulted in induction of ICE mRNA expression and enhancement of radiationinduced apoptosis (Tamura et al., 1995) . Lastly, transient cotransfection assays demonstrated that IRF-1 and the tumor suppressor p53 cooperatively upregulated gene expression of p21 (WAF1, CIP1), a member of the family of cyclin-dependent kinase (CDK) inhibitors which plays a primary role in cell cycle regulation (Ozawa et al., 1996) , implicating the involvement of cell cycle proteins in IRF-1-mediated cell growth regulation.
To further characterize IRF-1 tumor suppressor activity, we introduced IRF-1 into the tetracyclineresponsive regulatory system in murine NIH3T3 cells. We also established tetracycline-inducible cells expressing fusion proteins consisting of the DNA binding domains of IRF-1 or IRF-2 and the C-terminal transactivating domain of NF-kB RelA(p65). These chimeric proteins, designated IRF-1/RelA and IRF-2/ RelA, mimic IRF-1 in its ability to transactivate IFN-b gene transcription . Like IRF-1, induction of IRF-1/RelA and IRF-2/RelA expression resulted in cell growth arrest and apoptosis. PKR levels also increased following Tet-induced expression of IRF-1 and IRF/RelA. Most strikingly, induction of IRF-1 and IRF/RelA expression resulted in a signi®cant increase in STAT1(p91), suggesting that IRF-1 tumor suppressor activity may involve a novel mechanism which activates the JAK-STAT pathway through STAT1.
Results

Establishment of NIH3T3 cells inducibly expressing IRF-1 and the IRF/RelA fusion proteins
Cell lines constitutively expressing IRF-1 have been dicult to establish because of the growth-suppressive eects of IRF-1 (Kircho et al., 1993 (Kircho et al., , 1995 . Consequently, IRF-1, IRF-1/RelA and IRF-2/RelA (the latter two will be collectively referred to as IRF/ RelA) were introduced into the tetracycline-inducible system utilizing the reverse tTA activator (rtTA) (Gossen et al., 1992 (Gossen et al., , 1995 Shockett et al., 1995) , which permits doxycycline (Dox) inducible expression of IRF-1 and IRF/RelA (Figure 1 ). Eighteen to 50 potential clones from each of the rtTA-IRF-1 and rtTA-IRF/RelA cell lines were expanded individually Figure 1 Tetracycline regulated expression of IRF-1 and IRF/RelA. This system consists of two plasmid components; one encodes a tetracycline-responsive, VP16-based transactivator protein (rtTA) and the other contains the gene of interest ± IRF-1, IRF-1/ RelA or IRF-2/RelA ± downstream of the CMV t promoter. In the absence of doxycycline (a derivative of tetracycline), the rtTA protein is inactive (Gossen et al., 1995) . However, Dox-induced changes in protein conformation enables rtTA to bind regulatory tetracycline operon sequences present in the CMV t promoter and activate gene transcription. Active rtTA protein also binds to the CMV t promoter driving expression of itself, resulting in positive autoregulation of the rtTA gene Figure 2 illustrates the kinetics of expression of a representative clone from each of the rtTA-IRF-1 and rtTA-IRF/RelA cell lines. Each cell line possessed unique expression patterns. In the IRF-1 cell line, IRF-1 protein was detectable at peak levels within 18 h following addition of Dox ( Figure 2a , lane 3) and levels remained relatively constant thereafter. As measured by densitometry, peak IRF-1 levels were approximately 16-fold greater than uninduced levels. IRF-1/RelA protein was detectable within 12 h, reaching maximal levels at 48 h following Dox induction in the IRF-1/RelA cell line ( Figure 2b , lanes 2 and 5). Peak IRF-1/RelA expression was high ± approximately 53-fold greater than basal levels and threefold higher than the steady state level of endogenous RelA(p65) (Figure 2b, lanes 3 to 7) . Within 18 h of Dox induction, IRF-2/RelA protein was detectable in the rtTA-IRF-2/RelA cell line; peak expression was attained within 24 h with levels approximately 25-fold higher than basal levels ( Figure  2c , lanes 3 and 4). As represented by rtTA-IRF-1/RelA in Figure 2d , kinetics of mRNA induction correlated closely with protein expression (Figure 2b ). The relative Tet inducibility of the cell lines is depicted graphically in Figure 2e .
To test the functionality of the induced IRF-1 and IRF/RelA proteins, rtTA-IRF-1 and rtTA-IRF/RelA cells were analysed for DNA binding activity using electrophoretic mobility shift assays (EMSA); a representative EMSA is depicted in Figure 3 Dox for 0 ± 96 h was subjected to SDS ± PAGE and transferred to nitrocellulose membrane. IRF-1 levels were detected using an IRF-1 antibody and IRF/RelA levels were detected using a C-terminal NF-kB p65 antibody . ( 
SS 3 4 5 6 7 8 9 10 11 Figure 3 DNA binding activities in rtTA-IRF-1 and rtTA-IRF/RelA expressing cells. EMSA was performed on whole cell extracts (10 mg) derived from control rtTA, rtTA-IRF-1, and rtTA-IRF/RelA cells which were uninduced (lanes 1, 3, 6 and 9) or Dox induced for 48 h (lanes 2, 4, 7 and 10). To test the speci®city of complex formation, Dox-induced extracts were preincubated with IRF-1 (aF1; lane 5), or RelA(p65) (aRelA; lanes 8 and 11) antibody prior to probe addition. The 32 P-labeled probe corresponds to the ISRE of the IFN-a/b-inducible ISG-15 gene (5'-GATCGGGAAAGGGAAACCGAAACTGAAGCC-3'). The arrows correspond to the speci®c IRF-1 or IRF/RelA protein-DNA complex.`SS' corresponds to IRF/RelA supershift complexes , their potential to mimic IRF-1 in its role as a tumor suppressor was also assessed. Growth kinetics of the rtTA-IRF-1 and rtTA-IRF/RelA cell lines were analysed over a 5 day period following Dox induction ( Figure 4a ). In contrast to control rtTA cells, growth of IRF-1 and IRF/RelA expressing cells was signi®cantly reduced upon Dox induction, indicating that IRF/RelA proteins mimicked IRF-1 in cell growth inhibition. Growth rate correlated with the level of transgene expression, and the highly-expressing rtTA-IRF-1/RelA cells displayed a dramatic decrease in growth rate. Interestingly, peak expression of the cell lines at 24 ± 72 h after Dox induction also caused a low level of apoptosis in the cell population (approximately 10%), as assayed by microscopic analyses using the DNA intercalating dye acridine orange (Figure 4b ). At high concentrations, IRF/RelA appears to induce apoptosis, rather than cell growth arrest of NIH3T3 cells.
Recent evidence implicates IRF-1 in apoptotic cell death in response to DNA damage (Tamura et al., 1995; Ozawa et al., 1996) . To investigate whether IRF-1 modulated cell growth in response to serum starvation, growth kinetics of rtTA-IRF-1 and rtTA-IRF/RelA cells were analysed over a 6 day period in the absence or presence of Dox (Figure 4c ). Control rtTA cells in the absence or presence of Dox were growth arrested within 24 to 48 h after serum starvation; similarly, IRF-1 and IRF/RelA expressing cells in the absence of Dox were growth arrested. However, within 48 to 72 h after Dox induction under the same conditions, cell number decreased in the rtTA-IRF-1 and rtTA-IRF/RelA cell lines, indicating that IRF-1 and IRF/RelA expression caused cell death in serum starved cells. This result implicates IRF-1 as a cell growth regulator which can respond to cell stress in the form of serum starvation. Also, these studies further con®rm the ability of the IRF/RelA proteins 
Expression of PKR in the inducible IRF-1 and IRF/RelA inducible cell lines
The double stranded RNA activated serine-threonine kinase p68 kinase (PKR), is an IFN-inducible gene which plays an important role in the regulation of cell proliferation and leukemogenesis (Koromilas et al., 1992; Barber et al., 1993; Squire et al., 1993; Hanash et al., 1995) . To test whether IRF-1 expression aects PKR, the kinetics of expression of endogenous PKR was analysed in the rtTA-IRF-1 and rtTA-IRF/RelA cell lines following Dox induction. As shown in Figure 5 , endogenous PKR expression was induced by IRF-1 and IRF/RelA expression in the IRF-1 (Figure 5b ) and IRF/RelA cell lines (Figure 5c and d) but was unaected by Dox addition to the control rtTA cell line ( Figure  5a ). These results support the observation that IRF-1 tumor suppressor activity may involve PKR (Kircho et al., 1995) , and con®rms the ability of the IRF/ RelA fusion proteins to mimic IRF-1 transactivator function . STAT1 has been shown to activate transcription of the p21 (WAF1, CIP1) CDK inhibitor in response to induction by IFNg or EGF (epidermal growth factor), resulting in cell growth inhibition (Chin et al., 1996) . Tumor suppressor activity associated with IRF-1 in the inducible cell lines may be due to WAF1 activation by IRF-1-induced STAT1. To test this hypothesis, the kinetics of expression of endogenous 
Discussion
The role of IRF-1 as a tumor suppressor has been substantiated by several recent studies Willman et al., 1993; Tamura et al., 1995; Ozawa et al., 1996) . However, the mechanisms by which IRF-1 exerts its antioncogenic eects remain to be elucidated. To characterize IRF-1 tumor suppressor activity, we generated IRF-1 expressing cell lines with the tetracycline-inducible expression system to minimize basal expression and maximize transgene inducibility following doxycycline addition (Gossen et al., 1992 (Gossen et al., , 1995 Shockett et al., 1995) . Using these cell models, we demonstrate that inducible IRF-1 expression correlates with: (1) cell growth arrest and apoptosis: (2) inducible expression of PKR protein; (3) increased STAT1 gene expression and enhanced ISGF3 binding; and (4) constitutively increased p21(WAF1) CDK inhibitor levels. In addition, we showed that the IRF-1/RelA and IRF-2/ RelA fusion proteins mimicked IRF-1 in terms of cell growth inhibition, induction of apoptosis and gene activation. In previous co-expression studies, the IRF/ RelA fusion proteins, like IRF-1, activated expression of an intact IFN-b promoter-CAT reporter construct . The transactivating activity of IRF-1/ RelA and IRF-2/RelA was further demonstrated in this study, since inducible expression of the fusion proteins stimulated PKR and STAT1 gene expression. Since they exhibited similar eects, the use of the IRF/ RelA fusion genes strengthens the results of this study and imply that the phenotypic changes observed may result from aecting transcription of downstream genes which are regulated by IRF-1/IRF-2 sites. IRF-1 plays a role in apoptosis in response to DNA damage Tamura et al., 1995) . From the present study, IRF-1 also induced apoptosis during serum starvation. The pleiotropic nature of IRF-1 has important physiological implications in leukemogenesis, T-cell selection and maturation. Mice de®cient in the IRF-1 gene, while having normal numbers of immature CD8+CD47 and CD4+CD87 thymocytes, are de®cient in mature CD8+CD47 T-cells in the thymus (Matsuyama et al., 1993) , suggesting impairment of CD8+ cell maturation in the IRF-1 knockout mice. It has been suggested that IRF-1 may upregulate genes which are important for positive selection of CD8+ cells (Penninger et al., 1994) .
Like the IRF proteins, p68 kinase (PKR), a double stranded RNA activated serine-threonine kinase, is an IFN-inducible gene which plays an important role in the regulation of cell proliferation. Expression of wildtype PKR in NIH3T3 cells inhibited cell growth whereas expression of catalytically inactive PKR mutants resulted in malignant transformation and tumor formation in mice, implicating this kinase as a potential tumor suppressor (Koromilas et al., 1992) . Squire et al., 1993; Hanash et al., 1995) , raising the possibility of a role for PKR in leukemogenesis. As shown previously (Kircho et al., 1995) , we demonstrated that inducible IRF-1 expression resulted in upregulation of PKR protein levels. IRF-1 expression also resulted in a slight augmentation of PKR kinase activity (data not shown), suggesting that IRF-1 may regulate PKR gene expression rather than PKR activity. This ®nding suggests that inhibition of cell growth by IFN-inducible proteins such as IRF-1 may be due to regulation of other IFN induced proteins with anti-growth activities such as PKR.
Most interesting was the observation that inducible IRF-1 expression resulted in a dramatic increase in STAT1 (p91) levels. Furthermore, a percentage of the induced STAT1 was shown to be functional, since it bound to an ISRE DNA element. The latter result has several implications: (1) at least a portion of the induced STAT1 was phosphorylated, since phosphorylation is necessary for STAT1 DNA binding; (2) some active or phosphorylated STAT2 must also be present, since the ISGF3 complex requires active STAT1 and STAT2 as well as the ISGF3g (p48) member of the IRF family. However, STAT1 and STAT2 phosphorylation and DNA binding normally only occurs upon IFN-a/b induction Haspel et al., 1996; Shuai et al., 1993) . It would be of relevance to see whether the induced STAT1 is sucient to initiate activation of itself, as well as STAT2. Also interesting was the observation that although IFN stimulation of Dox-induced rtTA-IRF-1 and rtTA-IRF/RelA cells resulted in enhanced ISGF3 binding, DNA binding activity was not relatively higher than levels obtained in IFN-stimulated control cells, despite higher STAT1 protein levels. This phenomenon may be due to the constitutive activation/inactivation cycle of the STAT proteins Haspel et al., 1996) , such that only a certain percentage of STAT protein is activated and binds DNA at any given time.
STAT1 has been considered a gene acting upstream of IRF-1 and regulating expression of the IRF-1 promoter (Pine et al., 1994) . The present work suggests that IRF-1 itself, or an IRF-1 induced gene, regulates STAT1 expression at the transcriptional level. Two potential mechanisms may account for this observation: (1) Following IRF-1 upregulation in response to IFN induction through STAT1, the newly synthesized IRF-1 may in turn activate expression of STAT1, resulting in positive feedback regulation of IRF-1 expression. Such a mechanism could positively autoregulate IFN-mediated activities. It will be interesting to examine whether IRF-1 also regulates other members of the JAK-STAT pathway; (2) STAT1 has been shown to activate transcription of the p21 (WAF1, CIP1) CDK inhibitor in response to induction by IFNg or EGF (epidermal growth factor), resulting in cell growth inhibition (Chin et al., 1996) . We hypothesized that the tumor suppressor activity associated with IRF-1 in our inducible cell lines may be due to WAF1 activation by IRF-1-induced STAT1. If so, IRF-1 would potentially upregulate WAF1 by two mechanisms: (i) indirectly through activation of STAT1 expression; and (ii) either directly or indirectly, in cooperation with p53 (Ozawa et al., 1996) . However, the elevated WAF1 levels observed in the IRF-1 and IRF-1/RelA cells were constitutive, not inducible. Distinct STAT1 and WAF1 expression patterns in the rtTA-IRF-1 and rtTA-IRF-1/RelA cells, as well as the absence of WAF-1 despite STAT1 induction in the rtTA-IRF-2/ RelA cells, suggest that IRF-1 activation of WAF-1 is independent of STAT1.
Previously, it has been shown that overexpression of IRF-1 by cDNA transfection results in the`forced' induction of IFN-a/b in COS cells . Furthermore, in addition to their well-characterized antiproliferative activities, a potential role of IFNs in the transcriptional regulation of STAT1 has been recently demonstrated (Lehtonen et al., 1997) . Therefore, it is conceivable that the cell growth inhibition and upregulation of PKR, STAT1 and ISGF3 observed in the IRF-1 and IRF/RelA inducible cell lines may be mediated indirectly through IRF-1 or IRF/RelA ± induced IFNa/b. However, although endogenous IFN-b gene expression is dramatically induced in dsRNA/cycloheximide ± treated control rtTA cells, no IFN-b mRNA was detected by Northern and RT ± PCR analysis in Dox-induced IRF-1 and IRF/p65 cells (data not shown). This ®nding suggests that although the potential role of other members of the IFN family cannot be ruled out, IRF-1-mediated STAT1 upregulation is independent of IFN-b.
Why was WAF-1 not expressed in the rtTA-IRF-2/ RelA cells? Since the major dierence between the IRF-1, IRF-1/RelA and IRF-2/RelA protein structures was the IRF-2 DNA binding domain in IRF-2/RelA, we hypothesized that the inability of IRF-2/RelA to induce WAF-1 expression was perhaps due to the inability of IRF-2/RelA to recognize potential`IRFlike' recognition sites present in the WAF-1 promoter. Analysis of the WAF-1 promoter did not reveal any IRF DNA recognition sites (IRF-E), although three potential GAS consensus (5'-TTCNNNGAA-3') sequences were identi®ed: (1) 5'-CTTCCCGGAAG-3'; (2) 5'-TTTCTGAGAAAT-3'; and (3) 5'-CTTCTTGGA-AAAT-3', present at 7640, 72540, and 74183 nucleotides, respectively, from the mRNA start site. Induced extracts from the cell lines as well as recombinant IRF-1 and IRF-2 proteins were tested for DNA binding using the GAS element of the IFNginducible IFP-53 gene (5'-GATCCAGATTCTCA-GAAA-3'); however no distinct GAS binding was observed in any of the cell lines or with recombinant IRF-1 and IRF-2 (data not shown). It is therefore probable that WAF1 activation by IRF-1 and IRF/ RelA occurred by an indirect mechanism.
Recently Wong et al. (1997) demonstrated that PKR physically associated with STAT1, although PKR did not phosphorylate STAT1. Rather, PKR association inhibited STAT DNA binding and transactivation. Interestingly, the PKR-STAT1 interaction was disrupted in response to induction by IFN or dsRNA. How does this observation correlate with the present study which demonstrates upregulation of both PKR and STAT1 by IRF-1? It is conceivable that IRF-1-mediated eects may involve STAT1 activity which could be alleviated by PKR association with STAT1. It will be important to investigate the potential role of STAT1/PKR interactions in IRF-1-mediated cell growth regulation.
Materials and methods
Generation of plasmids
CMV t -rtTA contains the Moloney murine leukemia virusbased pBABE vector backbone, which contains a puromycin (puro) resistance gene under the control of the CMV promoter. Construction of the plasmid consisted of the consecutive insertion of three components into the polylinker site: the doxycycline-responsive promoter CMV t from the CMV t BL vector (a kind gift from A Cochrane), the rtTA gene from the pUHD172-1neo plasmid (Shockett et al., 1995) and the polyA fragment from the pSVK3 vector. neo CMV t BL was constructed in two steps. First, an intermediary plasmid (neo BL) was generated by ligation of a 3 kb XhoI/EcoRI fragment from the pMV7 vector (contains the neomycin (neo) resistance gene) to a 3.8 kb XhoI/EcoRI fragment from the CMV BL vector (contains the poly A site and the ampicillin (Amp) resistance gene). Second, a 450 bp XhoI (blunt)/NotI fragment of CMV t BL (contains the CMV t promoter) was cloned into the EcoRI (blunt)/NotI sites of neo BL. Generation of the IRF-1/RelA and IRF-2/RelA fusion proteins was previously described . CMV t -IRF-1 was constructed by cloning of an XbaI (blunt) IRF-1 cDNA fragment downstream of CMV t at the BamHI (blunt) site of neo CMV t BL. Analogously, for the construction of the CMV t -IRF-1/RelA and CMV t -IRF-2/ RelA plasmids, EcoRI/BamHI IRF-1/RelA and HindIII (blunt)/BamHI IRF-2/RelA cDNA fragments were inserted into the EcoRI/BamHI (for IRF-1/RelA) or EcoRI (blunt)/ BamHI (for IRF-2/RelA) sites of neo CMV t BL.
Cell culture and generation of IRF-1 and IRF/RelA cell lines Plasmid CMV t -rtTA was introduced into NIH3T3 cells by lipofection (Lipofectamine, Life Technologies, Inc.) according to manufacturer's instructions. Cells were selected beginning at 48 h for 1 week in Dulbecco's modi®ed Eagles medium (DMEM; high glucose) containing 10% heatinactivated calf serum, glutamine, antibiotics and 2.5 ng/ml puromycin (Sigma). Resistant cells carrying the CMV trtTA plasmid (rtTA cells) were then transfected with the CMV t -IRF-1, CMV t -IRF-1/RelA and CMV t -IRF-2/RelA plasmids. Cells were selected beginning at 48 h for a period of approximately 2 weeks in DMEM containing 10% heatinactivated calf serum, glutamine, antibiotics, 2.5 ng/ml puromycin and 400 mg/ml G418 (Life Technologies, Inc.).
Western blot analysis
To characterize kinetics of expression, rtTA, rtTA-IRF-1, rtTA-IRF-1/RelA and rtTA-IRF-2/RelA expressing cells were cultured in the presence of 1 mg/ml doxycycline (Sigma) for various times. Cells were then washed with phosphate-buered saline and lysed in 10 mM Tris-Cl pH 8.0, 60 mM KCl, 1 mM EDTA, 1 mM dithiothreitol (DTT), 0.5% Nonidet P-40 (NP-40), 0.5 mM phenylmethysulfonyl uoride (PMSF), 10 mg/ml leupeptin, 10 mg/ml pepstatin and 10 mg/ml aprotinin. Equivalent amounts of whole cell extract (20 mg) were subject to SDS-polyacrylamide gel electrophoresis (SDS ± PAGE) in a 10% polyacrylamide gel. After electrophoresis, the proteins were transferred to Hybond transfer membrane (Amersham) in a buer containing 30 mM Tris, 200 mM glycine and 20% methanol for 1 h. The membrane was blocked by incubation in phosphate-buered saline (PBS) containing 5% dried milk for 1 h and then probed with either IRF-1 (Santa Cruz), C-terminal NF-kB p65 , STAT1 (p91/p84; Santa Cruz), PKR (a gift from John Bell) or WAF-1 (Santa Cruz) antibody in 5% milk/PBS, at a dilution of 1 : 1000. These incubations were done at 48C overnight or at room temperature for 1 ± 3 h. After four 10 min washes with PBS, membranes were reacted with a peroxidase-conjugated secondary goat anti-rabbit or antimouse antibody (Amersham) at a dilution of 1 : 2500. The reaction was then visualized with the enhanced chemiluminescence detection system (ECL) as recommended by the manufacturer (Amersham Corp.).
Electromobility shift assay
Following 0 to 96 h culture in medium containing 1 mg/ml doxycycline, rtTA, rtTA-IRF-1, rtTA-IRF-1/RelA and rtTA-IRF-2/RelA cells were washed in phosphate-buffered saline and lysed in 50 mM Tris Cl pH 8.0, 0.1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.5 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml pepstatin, 10 mg/ml aprotinin, 0.5 ng/ ml chymostatin, and 0.25 mM microcystin. Equivalent amounts of whole cell extract (10 mg) were assayed for binding in gel shift analysis using a-32 P-dGTP-labeled double stranded oligonucleotide corresponding to the ISRE of the IFN-a/b-inducible ISG-15 gene (5'-GATCGG-GAAAGGGAAACCGAAACTGAAGCC-3'). The binding mixture (10 ml) contained 20 mM HEPES pH 7.9, 40 mM KCl, 1 mM MgCl 2 , 0.1 mM EGTA, 0.5 mM DTT, 10% glycerol, 250 ng/ml poly (dI-dC), 0.5 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml pepstatin, 10 mg/ml aprotinin and 1 ng (containing approximately 2610 5 c.p.m.) of probe. To test the speci®city of complex formation, Dox-induced extracts were preincubated with IRF-1 (Nguyen et al., 1995) or RelA(p65) antibody prior to probe addition. After 30 min of incubation with labeled probe at room temperature, the mixtures were loaded on a 6% nondenaturing polyacrylamide gel (50 : 1 crosslink) prepared in 0.26TBE buer. After running at 200 V for 2.5 h, the gel was dried and exposed to Kodak ®lm at 7708C overnight.
Analysis of cell growth and apoptosis
To analyse growth kinetics, rtTA, rtTA-IRF-1, rtTA-IRF-1/RelA and rtTA-IRF-2/RelA expressing cells were cultured in the presence of 1 mg/ml doxycycline for various times for a period of 5 days. Cells were initially plated at a density of 5610 4 cells per 35 mm dish and then counted using the Coulter counter every 24 h. Values obtained are the average of three experiments performed on two independent isolated clones per cell line. Experiments were performed either in complete medium (DMEM containing 10% heat-inactivated calf serum, glutamine, antibiotics, 2.5 ng/ml puromycin and 400 mg/ml G418) or serum starved medium (DMEM containing 0.5% heatinactivated calf serum, glutamine, antibiotics, 2.5 ng/ml puromycin and 400 mg/ml G418). To identify apoptotic cells, adherent and¯oating cells were harvested after 24 ± 48 h culture in the absence or presence of 1 mg/ml doxycycline, resuspended in DMEM containing 4 mg/ml of the DNA intercalating dye acridine orange (Sigma). The mixture was then viewed under u.v. illumination using a Leica¯uorescent microscope. To calculate percent apoptosis, a minimum of 200 cells were counted.
RNA preparation and Northern blot analysis
Total cellular RNA was isolated from rtTA-IRF-1/RelA cells following induction with 1 mg/ml doxycycline by the guanidium thiocyanate method (Chomczynski et al., 1987) . Poly(A) + enhanced RNA was isolated from the resulting total RNA by the Oligotex mRNA Kit (Qiagen Inc). Total RNA (20 mg) or poly(A) + enhanced RNA (2 mg) was denatured, electrophoresed in a denaturing formaldehyde/ 1.2% agarose gel, and transferred to nylon membrane. IRF-1/RelA and STAT1 mRNA were visualized by Northern blot hybridization using the ®rst 300 bp of the IRF-1 cDNA and the complete STAT1 (p91) cDNA, respectively, both labeled with [a-32 P]dCTP by nick translation.
